{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:24:27Z","timestamp":1762503867881,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.phro.2023.100443","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T12:55:59Z","timestamp":1682686559000},"page":"100443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Considerations for radiotherapy planning with MV photons using dose-to-medium"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-0975","authenticated-orcid":false,"given":"Diego","family":"Jurado-Bruggeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7324-8889","authenticated-orcid":false,"given":"Carles","family":"Mu\u00f1oz-Montplet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2023.100443_b0005","unstructured":"ICRU. ICRU Report 62, Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU 50). vol. os32. Bethesda, MD: 1999. 10.1093\/jicru\/os32.1.Report62."},{"key":"10.1016\/j.phro.2023.100443_b0010","unstructured":"ICRU. ICRU Report 83: Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT). Bethesda, MD: 2010. 10.1093\/jicru\/10.1.Report83."},{"key":"10.1016\/j.phro.2023.100443_b0015","doi-asserted-by":"crossref","unstructured":"Kry SF, Feygelman V, Balter P, Kn\u00f6\u00f6s T, Ma C \u2010M. C, Snyder M, et al. AAPM Task Group 329: Reference dose specification for dose calculations: dose\u2010to\u2010water or dose\u2010to\u2010muscle? Med Phys 2019:mp.13995. 10.1002\/mp.13995.","DOI":"10.1002\/mp.13995"},{"key":"10.1016\/j.phro.2023.100443_b0020","unstructured":"ICRU. ICRU Report 91, Prescribing, Recording, and Reporting of Stereotactic Treatments with Small Photon Beams. Bethesda, MD: 2017. 10.1007\/s00066-018-1416-x."},{"key":"10.1016\/j.phro.2023.100443_b0025","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2016.03.044","article-title":"Dose Specification for NRG Radiation Therapy Trials","volume":"95","author":"Gladstone","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100443_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2016.09.030","article-title":"Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases","volume":"97","author":"Al-Hallaq","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100443_b0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2021.03.006","article-title":"Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency","volume":"159","author":"Kry","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1088\/0031-9155\/60\/1\/309","article-title":"Dose to \u2018water-like\u2019 media or dose to tissue in MV photons radiotherapy treatment planning: still a matter of debate","volume":"60","author":"Andreo","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2023.100443_b0045","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1088\/0031-9155\/56\/10\/012","article-title":"Dose specification for radiation therapy: dose to water or dose to medium?","volume":"56","author":"Ma","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2023.100443_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmp.2018.10.024","article-title":"Dosimetric impact of Acuros XB dose-to-water and dose-to-medium reporting modes on VMAT planning for head and neck cancer","volume":"55","author":"Mu\u00f1oz-Montplet","year":"2018","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2023.100443_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phro.2018.01.004","article-title":"On the conversion of dose to bone to dose to water in radiotherapy treatment planning systems","volume":"5","author":"Reynaert","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0060","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abb6bc","article-title":"A new dose quantity for evaluation and optimisation of MV photon dose distributions when using advanced algorithms: proof of concept and potential applications","volume":"65","author":"Jurado-Bruggeman","year":"2020","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2023.100443_b0065","doi-asserted-by":"crossref","first-page":"e13572","DOI":"10.1002\/acm2.13572","article-title":"Maintaining dosimetric quality when switching to a Monte Carlo dose engine for head and neck volumetric-modulated arc therapy planning","volume":"23","author":"Feygelman","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2023.100443_b0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.meddos.2017.08.009","article-title":"AAA and AXB algorithms for the treatment of nasopharyngeal carcinoma using IMRT and RapidArc techniques","volume":"43","author":"Kamaleldin","year":"2018","journal-title":"Med Dosim"},{"year":"2017","series-title":"Fundamentals of ionizing radiation dosimetry","author":"Andreo","key":"10.1016\/j.phro.2023.100443_b0075"},{"year":"2017","series-title":"Eclipse photon and electron algorithms reference guide","author":"Varian Medical Systems","key":"10.1016\/j.phro.2023.100443_b0080"},{"key":"10.1016\/j.phro.2023.100443_b0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2020.09.038","article-title":"What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans","volume":"153","author":"Hernandez","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2021.04.042","article-title":"Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort","volume":"111","author":"van Dijk","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100443_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2016.11.015","article-title":"The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience","volume":"64","author":"Owosho","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0100","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/0284186X.2019.1643037","article-title":"Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations","volume":"58","author":"Aarup-Kristensen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01701-5","article-title":"Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma","volume":"16","author":"Kubota","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0110","first-page":"133","article-title":"Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study","author":"M\u00f6ring","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0115","first-page":"63","article-title":"Robust radiotherapy planning","author":"Unkelbach","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2023.100443_b0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phro.2019.08.005","article-title":"Dose to medium in head and neck radiotherapy: Clinical implications for target volume metrics","volume":"11","author":"Hardcastle","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2023.100443_b0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ejmp.2016.08.009","article-title":"Potential pitfalls of the PTV concept in dose-to-medium planning optimization","volume":"32","author":"Sterpin","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2023.100443_b0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/mp.15389","article-title":"Impact of the dose quantity used in MV photon optimization on dose distribution, robustness, and complexity","volume":"49","author":"Jurado-Bruggeman","year":"2022","journal-title":"Med Phys"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631623000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631623000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:14:29Z","timestamp":1762503269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631623000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":26,"alternative-id":["S2405631623000349"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2023.100443","relation":{},"ISSN":["2405-6316"],"issn-type":[{"type":"print","value":"2405-6316"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for radiotherapy planning with MV photons using dose-to-medium","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2023.100443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100443"}}